| INTRODUCTION
The prevalence of chronic rhinosinusitis (CRS) has been estimated at 10 .9% (range 6.9%-27.1%) in Europe, 1 while the mean prevalence of allergic rhinitis (AR) is 23% in European countries 2 and as high as 30% in Finland. 3 The adverse consequences of AR and CRS on health-related quality of life (HRQoL) and socioeconomic factors have recently been recognised. 1, 2 Both conditions have a demonstrated impact on the lower airways as well. 4, 5 A recent European
Union parliament symposium set a target for a 30% reduction in the disease burden of allergy-related and chronic airway diseases within the next 10 years. 6 While for both CRS and AR a diminished HRQoL has been associated with poor quality sleep, their relationship with obstructive sleep apnoea (OSA) remains unclear. 7, 8 Only a few studies have assessed HRQoL in rhinologic patient groups other than CRS and AR. Non-allergic rhinitis (NAR) is as common as allergic rhinitis, but only one study previously evaluated HRQoL in NAR. 9 This recent study demonstrated a diminished HRQoL amongst NAR patients using a rhinitis-specific questionnaire.
Other previous studies primarily evaluated select patients undergoing surgical procedures. For example, Hytönen et al 10 showed that the mean SF-6D (Short-Form Six-Dimension) utility score in CRS was lower than that observed in patients with Parkinson's disease or moderate chronic obstructive pulmonary disease. 8 The limitations that moderate to severe AR imposes on patients'
social lives have emerged as comparable to those amongst patients suffering from moderate to severe asthma. 2 This study aimed to measure the generic HRQoL in unselected patients referred to a tertiary healthcare unit due to nasal or sinonasal symptoms and to determine whether some diagnostic groups are more affected than others.
| PATIENTS AND METHODS

| Ethical considerations
This study was approved by the Research Ethics Board of the Helsinki University Hospital (Dnro 128/13/03/02/2013).
| Patients
This is a cross-sectional, questionnaire-based study designed to collect data on HRQoL amongst unselected patients with different rhinologic diseases or symptoms. The study was conducted in the 
Keypoints
• The generic HRQoL in rhinologic patients is substantially decreased.
• HRQoL in NAR was similar to HRQoL in other main diagnostic groups including CRS with and without nasal polyposis, AR and septal deviation.
• Rhinologic patients without OSA diagnosis suffered from poor sleeping and decreased vitality.
| 15D HRQoL questionnaire
The HRQoL questionnaire is a generic, standardised, validated, selfadministered HRQoL instrument that can be used both as a profile and a single-index score. 16 The questionnaire consists of 15 dimen- 
| Statistical analysis
Data analysis and statistics using the independent sample t tests were performed by a professional statistician. The difference between the groups was considered statistically significant at P < 0.05.
| RESULTS
A total of 349 patients returned questionnaires. Nine patients were excluded because of incomplete answers in the HRQoL questionnaires and three patients were excluded because they were under 18 years old. Thus, 337 patients were included in the analysis.
The response rate was recorded during a 1-month period (November 2014), reaching 46.3%. There were no statistically significant age or sex differences between respondents (mean age 48.6 years, 47.2% male) and non-respondents (44.1 years, 46.0% male).
The mean age (±SD, range) for all respondents was 50.2 years (15.5, 18-85); 50.4% were men (Table 1) . Among rhinologic patients, we found no difference in the mean 15D score between men and women (P = 0.549). However, we found a statistically significant sex The most frequent primary diagnosis was CRS (n = 121, 36%), followed by NAR (n = 62, 18%), AR (n = 44, 13%), and septal deviation (n = 35, 10%). Other common diagnoses included epistaxis (n = 10, 3%), anosmia (n = 10, 3%), headache (n = 6, 2%), and a deformity of the nose (n = 3, 1%). 
| 1489
We also found that 50% of patients never smoked, while 14.1%
(n = 47) were current smokers. The mean 15D score between never smokers, those who quit smoking, and those who were current smokers did not differ statistically (P = 0.309).
Only 128 patients answered the asthma question. Amongst were not weighted to reflect the age and sex distribution of the rhinologic patients.
Diagnosed OSA was found in 10.5% of rhinologic patients. We found that OSA patients scored poorer than the general population on all other dimensions except for seeing, eating and speech ( Figure 4 ). In addition, rhinologic patients without an OSA diagnosis scored poorer than the general population on all other dimensions except for moving 
| DISCUSSION
| Synopsis of key findings
This study demonstrates that HRQoL amongst rhinologic patients is substantially poorer compared to the age-and sex-standardised general population. We found that rhinologic patients performed significantly poorer on nearly all 15 dimensions of the generic 15D questionnaire. In particular, sleep, discomfort and symptoms, vitality, and breathing were affected amongst these patients. The most frequent primary rhinologic diagnoses in our clinic were CRS, with and without polyposis, followed by rhinitis, AR and NAR, and septal deviation. We found no statistically significant HRQoL differences between rhinologic groups. When compared to other disease groups, rhinologic patients fared poorer than, for example, patients entering treatment for head and neck cancer. Finally, OSA in rhinologic patients decreased the HRQoL, but patients without an OSA diagnosis still fared more poorly than the general population.
| Strengths of the study
The strength of this study is that these rhinologic patients were compared to a large age-and sex-standardised sample of the general population living in the same area as the patients. To our knowledge, no similar comparison and investigation of unselected rhinologic patients appears in the literature. Furthermore, the total number of patients in our study was higher than in most previously published HRQoL studies. [10] [11] [12] [13] In addition, the advantage of the 15D instrument used in this study is that it has also been used to study patients with several other health conditions from the same metropolitan area. 
15D dimensions
Patients General population *** *** *** * *** *** *** *** *** *** *** *** *** ** F I G U R E 2 The mean 15D profile of rhinologic patients (n = 337) compared to the general population standardised for age and sex (n = 1329). The mean 15D score for rhinologic patients is 0.865, while that for the population is 0.929; P < 0.001. *P < 0.05, **P < 0.01, ***P < 0.001 allows a comparison of our rhinologic patients to patients affected by other diseases.
| Limitations of the study
Despite the strengths of this study, we should also note several limitations. First, the response rate was estimated during a 1-month period, rather than amongst all patients invited to participate. The estimate for the response rate, 46%, is fairly low, although consistent with the average from a recent multicentre study.
1 Furthermore, the number of patients recruited to this study was high, and we found no statistically significant age or sex differences between respondents and non-respondents. In addition, we systematically examined physician-diagnosed asthma amongst only a portion of patients. Yet, its presence did not appear to decrease HRQoL. The diagnosis of obstructive sleep apnoea was based on the medical records of patients who visited our clinic. An OSA diagnosis was based on sleep studies interpreted by physicians at different levels and from various specialties from within the healthcare system. We did not, however, collect data on the number of patients tested for OSA.
| Comparison with other studies
Nasal obstruction is a typical symptom in all rhinologic diseases and may be a common factor explaining the impaired sleep dimension in the 15D scores and, consequently, substantial deterioration in HRQoL amongst our patients. However, it is important to note that the aetiology and pathophysiology of poor quality sleep are diverse.
Nasal problems, particularly, nasal obstruction, disturb sleep both subjectively (as perceived poor quality sleep) and objectively (as observed in sleep studies). 22 Nasal obstruction can cause snoring and mild sleep-disordered breathing 23 and may predispose individuals to OSA, as shown in other causes of upper airway obstruction. 24, 25 OSA results in excessive daytime sleepiness and is also known to considerably worsen general HRQoL amongst patients along important domains (ie, sleeping, elimination, depression, vitality and sexual activity). 26 We compared patients with different rhinologic diseases with and without OSA to the general population and observed that an OSA diagnosis clearly explained part of the poor HRQoL amongst our patients. In this study with a cohort of unselected rhinologic patients evaluated using a generic measurement, OSA negatively affected sleep and several other dimensions. A clinically important impairment to HRQoL along the same dimensions was also found in rhinologic patients without an OSA diagnosis. The treatment of nasal disease in non-OSA patients has been shown to improve sleep quality. 7 The effect of NAR on quality of life was first studied only recently. 9 HRQoL in NAR patients was at least equally impaired compared to AR when investigated using a rhinitis-specific questionnaire. Our results revealed a similar decrease in general HRQoL accompanying NAR and AR, equalling that in CRS, thus illustrating the detrimental effect of NAR on patient health.
An unexpected finding in our study was that HRQoL did not differ between different rhinologic groups. It appears that structural and inflammatory diseases categorised by the primary diagnosis had a similar detrimental effect on HRQoL. Croy et al investigated the preoperative HRQoL amongst septoplasty, sinus surgery, and sinus and septal surgery groups. According to their results, sinus patients had a significantly lower HRQoL measured using the generic SF-36 instrument, compared to septum patients irrespective of age and sex. 11 In another study, a comparison of the preoperative HRQoL amongst four rhinologic surgical groups also showed differences between these groups. 13 By contrast, a recent Finnish study investigating septoplasty and FESS patients preoperatively reported results comparable to our study. HRQoL was similarly and significantly impaired between the two patient groups when compared with the control group. 12 In the present study, we evaluated unselected rhinologic patients, rather than only patients awaiting surgical treatment. Therefore, our data are new and our findings represent HRQoL amongst rhinological clinic patients referred for special care.
Another new finding in our study was the poorer HRQoL amongst rhinologic patients compared to patients with other chronic diseases, such as those with head and neck cancer or uterine disorders. 20, 21 Although other patient groups were studied at different
The mean 15D scores for rhinologic patients compared with patients with depression (n = 89, mean age 40 y, 41% men), Addison's disease (n = 107, mean age 50 y, 20% men), head and neck cancer (n = 214, mean age 63 y, 66% men), and hysterectomy (n = 337, mean age 53 y) times and the comparison was not standardised for age and sex, the difference appears real. That is, our patients were in the same age Level value
15D dimensions
General population
Patients with OSA diagnosis *** *** *** *** ** ** ** ** ** * * * F I G U R E 4 The mean 15D profile for rhinologic patients with diagnosed obstructive sleep apnoea (with OSA, n = 33) compared to that of the age-and sex-standardised general population. The mean 15D score for rhinologic patients with OSA is 0.816 while that for the population is 0.928; P < 0.001. *P < 0.05, **P < 0.01, ***P < 0.001 Level value
Patients without OSA diagnosis ** *** *** *** *** *** *** *** *** *** *** *** *** 
| CONCLUSIONS
This cross-sectional, questionnaire-based study shows that HRQoL of patients is substantially impaired regardless of the different rhinologic diseases when compared to the age-and sex-standardised general population. In general, a lower HRQoL in NAR similar to AR and CRS was found. Moreover, OSA impairs HRQoL in rhinologic patients, but HRQoL is also low in patients without an OSA diagnosis. In clinical practice, we should pay more attention to improving the quality of sleep amongst rhinologic patients.
